• Non-Viral Liver Disease in HIV+ - Increased Prevalence of Liver Fibrosis in PLWH Increased Prevalence of Liver Fibrosis in People Living With Human Immunodeficiency Virus Without Viral Hepatitis Compared to Population Controls - (03/02/21)
   
  
• HIV+ Women Have Higher Burden of Comorbidities vs HIV- Women / Accelerated-Earlier by 10 Years - (03/02/21)
   
  
• CROI: ViiV Healthcare to present new data on long-acting regimens for HIV prevention and treatment, alongside pipeline advances at CROI 2021 - (03/02/21)
   
  
• ViiV Healthcare Submits Supplemental New Drug Application to US FDA for Expanded Use of Cabenuva (cabotegravir, rilpivirine) as an HIV Treatment for Use Every 2-Months - (02/26/21)
   
  
• Cognitive ageing is premature among a community sample of optimally treated people living with HIV - (02/26/21)
   
  
• Motor function declines over time in human immunodeficiency virus and is associated with cerebrovascular disease, while HIV-associated neurocognitive disorder remains stable - (02/26/21)
   
  
• HIV+ Women & MSM: aging & other issues - (02/22/21)
   
  
• Loss of viral suppression by 31% in SF is deleterious to the individual and hinders treatment-as-prevention: the COVID-19 pandemic is threatening the goals of the US EHE initiative. - (02/22/21)
   
  
• Indirect HIV morbidity and mortality due to COVID-19- PLWH presenting with more advanced HIV - (02/22/21)
   
  
More HIV Articles...
 

• Joseph Sonnabend, Early Force in Fight Against AIDS, Dies at 88 - (01/02/21)
   
  
• NIAID Renews Weill Cornell Medicine Grant for Advancing Prevention and Treatment Research for HIV - (12/04/20)
   
  
• ViiV Healthcare and the Medicines Patent Pool expand access to dolutegravir-based regimens for people living with HIV in Azerbaijan, Belarus, Kazakhstan and Malaysia with innovative new licensing agreement - (11/28/20)
   
  
More News Updates Articles...
 

• EASL: HCV Micro-Elimination Funding Grants Available
   
  
• Racial disparities in hepatocellular carcinoma, Hepatitis C‐positive Black patients develop hepatocellular carcinoma at earlier stages of liver disease and present with a more aggressive phenotype - (02/27/21)
   
  
• AASLD Selected Highlights - HCV Elimination, Screening, Treatment - (02/26/21)
   
  
• New HCV / HBV Bill in California - (02/26/21)
   
  
• The persistence of underreporting of hepatitis C as an underlying or contributing cause of death, 2011-2017 - (02/23/21)
   
  
• AASLD: Shelter-Based Integrated HCV Care Model is Effective in Scaling up HCV Testing and Treatment in Homeless Clients Across Two Large Urban Settings - (02/22/21)
   
  
• County‐Level Variation in Hepatitis C Virus Mortality and Trends in the United States, 2005‐2017 - (02/21/21)
   
  
More Hep C Articles...
 

• Tenofovir Alafenamide to Prevent Perinatal Hepatitis B Transmission: A Multicenter, Prospective, Observational Study - (04/20/21)
   
  
• AASLD: Infant Outcomes in HIV/Hepatitis B Co-Infected Women Initiating ART in the Promoting Maternal and Infant Survival Everywhere Study - (12/10/20)
   
  
• AASLD: Safety And HBV Efficacy Of Antiretroviral Therapy In Women With HIV And HBV In The Promoting Maternal And Infant Survival Everywhere Study (PROMISE) - (12/10/20)
   
  
More Hep B Articles...
 

List not necessarily listed here in order of date being held.